OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022
17 févr. 2022 08h00 HE
|
OPKO Health, Inc.
MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S....
RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
03 févr. 2022 08h30 HE
|
OPKO Health, Inc.
MIAMI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has initiated the commercial launch of RAYALDEE® (extended...
Japan’s MHLW Approves Pfizer and OPKO’s NGENLA® (Somatrogon), a New Long-Acting Treatment for Pediatric Growth Hormone Deficiency
20 janv. 2022 08h00 HE
|
OPKO Health, Inc.; Pfizer Japan Inc.
TOKYO and MIAMI, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Pfizer Japan Inc. and OPKO Health, Inc. (NASDAQ: OPK) announced today that the next generation long-acting growth hormone injection, NGENLA®...
OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients
23 déc. 2021 08h00 HE
|
OPKO Health, Inc.
MIAMI, Dec. 23, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces preliminary topline results from its Phase 2 trial with RAYALDEE® to treat mild-to-moderate COVID-19. This study...
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
08 déc. 2021 08h00 HE
|
OPKO Health, Inc.
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for...
OPKO Health Announces the Passing of Director Dr. Richard Lerner
06 déc. 2021 08h00 HE
|
OPKO Health, Inc.
MIAMI, Dec. 06, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that Director Richard A. Lerner, M.D. passed away on December 2nd at the age of 83. Dr. Lerner had served as a...
OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference
29 nov. 2021 08h00 HE
|
OPKO Health, Inc.
MIAMI, Nov. 29, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Piper Sandler 33rd Annual Virtual Healthcare Conference taking...
OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results
28 oct. 2021 16h15 HE
|
OPKO Health, Inc.
MIAMI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2021. Business Highlights ...
OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021
25 oct. 2021 10h57 HE
|
OPKO Health, Inc.
MIAMI, Oct. 25, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended September 30, 2021, as well as discuss financial...
Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
24 sept. 2021 16h24 HE
|
OPKO Health, Inc.
NEW YORK and MIAMI, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has extended the...